ID   A-1663
AC   CVCL_D137
SY   A1663
DR   cancercelllines; CVCL_D137
DR   Cosmic; 735610
DR   Wikidata; Q54606400
RX   PubMed=375235;
RX   PubMed=3945555;
CC   From: Aaronson, Stuart A.; Mt. Sinai Medical Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (PubMed=3945555).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 13
//
RX   PubMed=375235; DOI=10.1073/pnas.76.3.1288; PMCID=PMC383236;
RA   Sherwin S.A., Sliski A.H., Todaro G.J.;
RT   "Human melanoma cells have both nerve growth factor and nerve growth
RT   factor-specific receptors on their cell surfaces.";
RL   Proc. Natl. Acad. Sci. U.S.A. 76:1288-1292(1979).
//
RX   PubMed=3945555; DOI=10.1093/nar/14.2.843; PMCID=PMC339468;
RA   Valenzuela D.M., Groffen J.;
RT   "Four human carcinoma cell lines with novel mutations in position 12
RT   of c-K-ras oncogene.";
RL   Nucleic Acids Res. 14:843-852(1986).
//